Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.62 USD | -0.10% | -0.25% | -15.05% |
11:25am | India's Alembic Pharma posts higher Q4 profit on strong N.America sales | RE |
May. 07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
Financials (USD)
Sales 2024 * | 46.02B | Sales 2025 * | 46.16B | Capitalization | 88.52B |
---|---|---|---|---|---|
Net income 2024 * | -5.4B | Net income 2025 * | 10.22B | EV / Sales 2024 * | 2.78 x |
Net Debt 2024 * | 39.2B | Net Debt 2025 * | 31.85B | EV / Sales 2025 * | 2.61 x |
P/E ratio 2024 * |
-16.6
x | P/E ratio 2025 * |
8.25
x | Employees | 34,100 |
Yield 2024 * |
5.51% | Yield 2025 * |
5.79% | Free-Float | 69.28% |
Latest transcript on Bristol-Myers Squibb Company
1 day | -0.84% | ||
1 week | -1.22% | ||
Current month | -0.61% | ||
1 month | -14.54% | ||
3 months | -10.35% | ||
6 months | -16.69% | ||
Current year | -14.89% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 15-01-31 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 19-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 19-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 16-03-31 |
Derica Rice
BRD | Director/Board Member | 59 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.97% | 0 M€ | +12.09% | - | |
4.99% | 2 M€ | -.--% | ||
4.01% | 0 M€ | +5.54% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 43.58 | -0.22% | 212 511 |
24-05-08 | 43.67 | -0.84% | 11,928,339 |
24-05-07 | 44.04 | +0.32% | 11,026,912 |
24-05-06 | 43.9 | -0.20% | 9,127,651 |
24-05-03 | 43.99 | +0.66% | 12,104,489 |
Delayed Quote Nyse, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.89% | 88.52B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.98% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- BMY Stock